Anabolic therapy a winner for osteoporosis
A novel anabolic treatment for osteoporosis has come up trumps in a randomised controlled trial, showing a substantial reduction of fractures in postmenopausal women.
In the landmark ACTIVE trail, abaloparatide-SC reduced fractures and increased bone mineral density for a broad range of postmenopausal women with osteoporosis.
The findings held regardless of baseline bone density, age and previous fracture history, according to the US researchers writing in the Journal of Bone and Mineral Research.
They suggest anabolic therapy could provide more